Search Results 1-10 of 15884 for Fibronolytic

  1. Von Willebrand disease - Diagnosis & treatment - Mayo Clinic

    These anti-fibrinolytic medications — such as aminocaproic acid (Amicar) and tranexamic acid (Cyklokapron, Lysteda) — can help stop bleeding by slowing the ...

  2. Arteriosclerosis / atherosclerosis - Diagnosis and treatment - Mayo Clinic

    Fibrinolytic therapy. If a clot in an artery is blocking blood flow, your provider may use a clot-dissolving drug to break it apart. Coronary artery bypass ...

  3. Tranexamic Acid (Oral Route) Description and Brand Names - Mayo Clinic

    Tranexamic acid is an antifibrinolytic agent. It works by blocking the breakdown of blood clots, which prevents bleeding. This medicine is available only with ...

  4. Hemophilia - Diagnosis and treatment - Mayo Clinic

    Also known as anti-fibrinolytics, these medications help prevent clots from breaking down. Fibrin sealants. These can be applied directly to wound sites to ...

  5. Prosthetic valve thrombosis: Time is critical - Mayo Clinic

    The overall risk of bleeding and thromboembolism with fibrinolytic therapy of left-sided valves is 17.8 percent and is directly related to thrombus size.

  6. Prehospital Tranexamic Acid Use for Traumatic Brain Injury - Mayo Clinic

    Mechanistic outcomes: Alterations in fibrinolysis based on fibrinolytic pathway mediators and degree of clot lysis based on TEG. A multi-center double-blind ...

  7. Vascular Boot Warming Program After Acute Deep Vein Thrombosis (DVT) ± Pulmonary Embolism (PE) - Mayo Clinic

    The role of fibrinolytic therapy in patients with intermediate-risk pulmonary embolism is controversial. ... fibrinolytic system. This study was performed ...

  8. Infigratinib (Oral Route) Description and Brand Names - Mayo Clinic

    Infigratinib is used to treat cholangiocarcinoma (bile duct cancer) that has spread or cannot be removed by surgery. It is used in patients who have already ...

  9. Warfarin side effects: Watch for interactions - Mayo Clinic

    Antiplatelet, anticoagulant, and fibrinolytic drugs. In: Harrison's Principles of Internal Medicine. 21st ed. McGraw Hill; 2022. https://accessmedicine ...

  10. Fibrin hydrogels provide a scaffold for transplantation of RPE monolayers - Mayo Clinic

    Again, even without the addition of exogenous fibrinolytic enzymes, the RPE is able to degrade the fibrin gel rapidly." "Our data suggest that fibrin ...